TickerFactsScreenerDevelopers

GALECTIN THERAPEUTICS INC (GALT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$4.88M2011: -$10.41M2012: -$9.90M2013: -$12.10M2014: -$15.43M2015: -$20.08M2016: -$21.48M2017: -$16.25M2018: -$13.60M2019: -$13.44M2020: -$23.44M2021: -$30.18M2022: -$38.35M2023: -$38.07M2024: -$42.43M2025: -$20.09M-$20.09M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$20.09M+52.7%
2024-$42.43M-11.5%
2023-$38.07M+0.7%
2022-$38.35M-27.1%
2021-$30.18M-28.7%
2020-$23.44M-74.5%
2019-$13.44M+1.2%
2018-$13.60M+16.3%
2017-$16.25M+24.4%
2016-$21.48M-7.0%
2015-$20.08M-30.1%
2014-$15.43M-27.5%
2013-$12.10M-22.3%
2012-$9.90M+4.9%
2011-$10.41M-113.2%
2010-$4.88M—